When Do Smartwatch Heart Rate Concerns in Children Indicate Arrhythmia?

J Pediatr

Department of Pediatrics, University of Michigan, Ann Arbor, MI.

Published: December 2023

Objective: To determine the incidence and predictors of true arrhythmia in pediatric patients presenting with concerns about smartwatch cardiac data.

Study Design: Single-center, retrospective cohort study of children aged 10-18 years who had presented to a pediatric cardiology clinic between January 2018 and December 2021 with concerns related to smartwatch cardiac data. The primary study outcome was diagnosis of arrhythmia based on clinical evaluation or documentation of arrhythmia by clinical testing.

Results: There were 126 patients (mean age 15.6 ± 2.4 years) who presented with a smartwatch-based rhythm concern, with tachycardia in 89%. In all, 19 of 126 (15%) patients were diagnosed with true arrhythmia. The odds of a true arrhythmia diagnosis with symptoms vs no symptoms were 3.2 (95% CI 0.7-14.5), and with heart rate (HR) ≥190 beats/min vs HR <190 beats/min, it was 14.3 (95% CI 3.8-52.8). The positive predictive value of HR ≥190 beats/min and symptoms together to predict arrhythmia was only 39% (95% CI 28-52). The negative predictive value for arrhythmia having neither symptoms nor HR >190 was 95% (95% CI 75-99).

Conclusion: The likelihood of a true arrhythmia in pediatric patients presenting with a smartwatch-based HR concern was low. Rarely, smartwatch electrograms or trend data were sufficient for arrhythmia diagnosis.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jpeds.2023.113717DOI Listing

Publication Analysis

Top Keywords

true arrhythmia
16
heart rate
8
arrhythmia pediatric
8
pediatric patients
8
patients presenting
8
concerns smartwatch
8
smartwatch cardiac
8
arrhythmia diagnosis
8
arrhythmia
7
smartwatch
4

Similar Publications

Fetal and neonatal cardiac tumors are rare and often benign. Clinical presentation is primarily related to mass effect, pericardial effusion or arrhythmia. Prenatal detection can assist with risk assessment and inform optimal delivery plan and postnatal management.

View Article and Find Full Text PDF

Artifacts at Cardiac MRI: Imaging Appearances and Solutions.

Radiographics

January 2025

From the Department of Radiology, Cardiovascular Imaging, Mayo Clinic, 200 1st St SW, Rochester, MN 559905 (P.S.R., P.A.A.); Department of Radiology, Division of Cardiothoracic Imaging, Jefferson University Hospitals, Philadelphia, Pa (B.S.); Department of Radiology, Baylor Health System, Dallas, Tex (P.R.); Department of Diagnostic Radiology, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong SAR (M.Y.N.); and Department of Diagnostic Radiology, Cleveland Clinic, Cleveland, Ohio (M.A.B.).

Cardiac MRI (CMR) is an important imaging modality in the evaluation of cardiovascular diseases. CMR image acquisition is technically challenging, which in some circumstances is associated with artifacts, both general as well as sequence specific. Recognizing imaging artifacts, understanding their causes, and applying effective approaches for artifact mitigation are critical for successful CMR.

View Article and Find Full Text PDF

It was widely accepted that malignant ventricular arrhythmias (VA) are the main direct initial cause for cardiac arrest and sudden cardiac death (SCD), but diverging data tended to demonstrate that asystole or pulseless activity were becoming the most prevalent cardiac rhythms at the time of cardiac arrest. We challenge here these conceptions and reinforce the persisting prominent role of VA in SCD.

View Article and Find Full Text PDF

The rising demand for genetic counseling has prompted the implementation of various innovative service delivery models, such as patient webinars, videos, chatbots, and the integration of genetic testing into mainstream healthcare. To ensure patients receive adequate information for informed decision-making, validated measures to assess these models are essential but currently limited in the setting of inherited heart disease. We aimed to develop and initiate validation of a cardiac knowledge scale, as part of the Multidimensional Model of Informed Choice measure, to assess whether patients (probands and family members) with inherited cardiomyopathies, arrhythmias, and aortopathies are provided with sufficient knowledge to make informed decisions about genetic testing.

View Article and Find Full Text PDF

Background: Complete heart block (CHB) is a relatively common complication in post-acute myocardial infarction (AMI) patients. Data on the incidence and consequences of CHB in patients with ST-segment elevation myocardial infarction (STEMI) are limited. Besides serving as an indicator of widespread myocardial injury, the development of CHB in STEMI is also associated with a higher risk of sudden cardiac death.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!